News
A new ICES study has found that 1.74 million patients in Ontario are attached to family physicians aged 65 or older, and that ...
Investigating tirzepatide's role in Alzheimer's reveals its potential to improve brain function and reduce inflammation, ...
Huntington's disease has long defied attempts to rescue suffering neurons. A new study in Cell Reports shows that ...
Qureight's synthetic study arms validate clinical efficacy in pioneering rare lung disease treatment
Qureight, a deep-learning analytics company accelerating drug development through AI-powered data curation, today announced that its digitally-twinned synthetic control arm has been used in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results